JPWO2021112220A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021112220A5
JPWO2021112220A5 JP2021562745A JP2021562745A JPWO2021112220A5 JP WO2021112220 A5 JPWO2021112220 A5 JP WO2021112220A5 JP 2021562745 A JP2021562745 A JP 2021562745A JP 2021562745 A JP2021562745 A JP 2021562745A JP WO2021112220 A5 JPWO2021112220 A5 JP WO2021112220A5
Authority
JP
Japan
Prior art keywords
adrenomedullin
peptide
group
agent according
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562745A
Other languages
English (en)
Japanese (ja)
Other versions
JP7498882B2 (ja
JPWO2021112220A1 (fr
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/045235 external-priority patent/WO2021112220A1/fr
Publication of JPWO2021112220A1 publication Critical patent/JPWO2021112220A1/ja
Publication of JPWO2021112220A5 publication Critical patent/JPWO2021112220A5/ja
Application granted granted Critical
Publication of JP7498882B2 publication Critical patent/JP7498882B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562745A 2019-12-05 2020-12-04 異常タンパク質蓄積性神経変性疾患の治療剤 Active JP7498882B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019220695 2019-12-05
JP2019220695 2019-12-05
PCT/JP2020/045235 WO2021112220A1 (fr) 2019-12-05 2020-12-04 Agent thérapeutique pour maladie neurodégénérative avec accumulation anormale de protéines

Publications (3)

Publication Number Publication Date
JPWO2021112220A1 JPWO2021112220A1 (fr) 2021-06-10
JPWO2021112220A5 true JPWO2021112220A5 (fr) 2022-07-29
JP7498882B2 JP7498882B2 (ja) 2024-06-13

Family

ID=76221768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562745A Active JP7498882B2 (ja) 2019-12-05 2020-12-04 異常タンパク質蓄積性神経変性疾患の治療剤

Country Status (2)

Country Link
JP (1) JP7498882B2 (fr)
WO (1) WO2021112220A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012571A1 (fr) * 2007-07-20 2009-01-29 Genesys Venture Inc. Kallikréine tissulaire destinée au traitement de maladies associées à la protéine amyloïde
JOP20190001B1 (ar) * 2011-11-03 2022-03-14 Bayer Pharma AG عقار أولي معتمد على جليكول عديد إثيلين من أدرينومدالين واستخدامه
US11414474B2 (en) * 2014-03-20 2022-08-16 University Of Miyazaki Long-acting adrenomedullin derivatives
SG10202008963QA (en) * 2015-09-18 2020-10-29 Univ Miyazaki Long-acting adrenomedullin derivative

Similar Documents

Publication Publication Date Title
FI72732B (fi) Foerfarande foer framstaellning av nya, i 8-staellning aminosyraestergrupp innehaollande, angiotensin-ii-antagoniserande oktapeptidestrar.
AU2012326026B2 (en) Peptidomimetic macrocyles
BR112014015156A2 (pt) análogos de insulina à base de ctp, seus métodos de produção e uso no tratamento de hiperglicemia, bem como sequência de ácido nucleico e célula hospedeira
US20180371044A1 (en) Peptidomimetic macrocycles
JP2020502051A5 (fr)
WO2004020462A1 (fr) Antagoniste de cxcr4 et son utilisation
BG65926B1 (bg) Кахалалидни съединения
JP2011518179A5 (fr)
JP2009532384A5 (fr)
JPH06506699A (ja) 抗血栓性ペプチドおよび偽ペプチド
JPH0753591A (ja) 胃腸運動活性を抑制するモチリン類似ポリペプチド
JPWO2021112220A5 (fr)
JP2019038772A5 (fr)
AU684511B2 (en) Oligopeptides derived from C-reactive protein fragments
JPH0770178A (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
WO2022177878A1 (fr) Antagonistes du récepteur du peptide-1 de type glucagon
AU2022222674A9 (en) Glucagon-like peptide-1 receptor antagonists
JPWO2021112235A5 (fr)
RU2760133C1 (ru) Амиды гептапептида для лечения HMGB1-зависимых заболеваний
JPH08501066A (ja) ペプチド化合物
TW202245828A (zh) 用於預防或治療肺部疾病的包括gip衍生物或其長效共軛物的藥學組成物
EP0722459B1 (fr) Penta/peptides ou hexapeptides hemoregulateurs
EP4230219A1 (fr) Composition pharmaceutique comprenant un triple agoniste du glucagon/glp-1/gip ou un conjugué à action prolongée correspondant pour la prévention ou le traitement de maladies associées au lupus
US6342481B1 (en) Oligopeptides derived from C-reactive protein fragments
JPH06509571A (ja) タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物